Arcadia Biosciences, Inc. (RKDA) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Arcadia Biosciences, Inc. (RKDA) Bundle
Explore the financial prospects of Arcadia Biosciences, Inc. (RKDA) with our user-friendly DCF Calculator! Enter your assumptions regarding growth, margins, and costs to calculate the intrinsic value of Arcadia Biosciences, Inc. (RKDA) and inform your investment strategy.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.2 | 8.0 | 6.8 | 10.0 | 5.3 | 6.5 | 7.8 | 9.5 | 11.5 | 13.9 |
Revenue Growth, % | 0 | 587.25 | -15.61 | 46.84 | -46.46 | 21.19 | 21.19 | 21.19 | 21.19 | 21.19 |
EBITDA | -28.7 | -5.4 | -23.3 | -13.6 | -13.9 | -6.0 | -7.3 | -8.9 | -10.8 | -13.0 |
EBITDA, % | -2452.69 | -67.72 | -343.17 | -137.07 | -261.5 | -93.54 | -93.54 | -93.54 | -93.54 | -93.54 |
Depreciation | .2 | .7 | 1.0 | 1.4 | .3 | .8 | .9 | 1.1 | 1.4 | 1.7 |
Depreciation, % | 16.6 | 8.24 | 15.41 | 13.69 | 5.38 | 11.86 | 11.86 | 11.86 | 11.86 | 11.86 |
EBIT | -28.9 | -6.1 | -24.3 | -15.0 | -14.2 | -6.1 | -7.5 | -9.0 | -10.9 | -13.3 |
EBIT, % | -2469.29 | -75.96 | -358.58 | -150.76 | -266.89 | -95.19 | -95.19 | -95.19 | -95.19 | -95.19 |
Total Cash | 25.3 | 25.7 | 28.7 | 20.6 | 11.6 | 6.5 | 7.8 | 9.5 | 11.5 | 13.9 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .6 | 1.4 | 1.4 | 1.2 | .5 | 1.4 | 1.7 | 2.1 | 2.6 | 3.1 |
Account Receivables, % | 51.5 | 17.5 | 20.21 | 12.26 | 9.64 | 22.22 | 22.22 | 22.22 | 22.22 | 22.22 |
Inventories | 1.8 | 3.8 | 4.4 | 2.6 | 2.0 | 3.6 | 4.3 | 5.2 | 6.3 | 7.7 |
Inventories, % | 153.46 | 47.45 | 65.38 | 25.82 | 36.74 | 55.08 | 55.08 | 55.08 | 55.08 | 55.08 |
Accounts Payable | .5 | .7 | 1.4 | .9 | .8 | 1.2 | 1.5 | 1.8 | 2.2 | 2.7 |
Accounts Payable, % | 42.09 | 9.04 | 20.81 | 9.09 | 15.03 | 19.21 | 19.21 | 19.21 | 19.21 | 19.21 |
Capital Expenditure | -1.5 | -2.3 | -1.0 | -.1 | .0 | -1.9 | -2.3 | -2.7 | -3.3 | -4.0 |
Capital Expenditure, % | -126.35 | -29.06 | -14.85 | -0.72318 | -0.09380863 | -28.95 | -28.95 | -28.95 | -28.95 | -28.95 |
Tax Rate, % | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 | -6.26 |
EBITAT | -28.9 | -6.0 | -24.3 | -15.0 | -15.1 | -6.1 | -7.4 | -9.0 | -10.9 | -13.2 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -32.1 | -10.2 | -24.2 | -12.2 | -13.6 | -9.3 | -9.6 | -11.6 | -14.0 | -17.0 |
WACC, % | 9.76 | 9.75 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 | 9.76 |
PV UFCF | ||||||||||
SUM PV UFCF | -45.5 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -17 | |||||||||
Terminal Value | -224 | |||||||||
Present Terminal Value | -140 | |||||||||
Enterprise Value | -186 | |||||||||
Net Debt | -6 | |||||||||
Equity Value | -180 | |||||||||
Diluted Shares Outstanding, MM | 1 | |||||||||
Equity Value Per Share | -145.83 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real RKDA financials.
- Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly visualize how your inputs affect Arcadia Biosciences’ valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive Data: Arcadia Biosciences’ historical financial statements and pre-filled projections.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: Observe Arcadia Biosciences’ intrinsic value update instantly.
- Intuitive Visual Outputs: Dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the prebuilt Excel template featuring Arcadia Biosciences, Inc.’s (RKDA) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see recalculated results, including Arcadia Biosciences, Inc.’s (RKDA) intrinsic value.
- Step 5: Make well-informed investment decisions or create reports based on the results.
Why Choose This Calculator for Arcadia Biosciences, Inc. (RKDA)?
- User-Friendly Interface: Perfect for both novice and experienced users.
- Customizable Inputs: Adjust parameters to fit your specific analysis needs.
- Real-Time Feedback: Watch as Arcadia’s valuation updates instantly with your changes.
- Pre-Loaded Data: Comes equipped with Arcadia’s latest financial information for immediate insights.
- Relied Upon by Experts: A go-to tool for investors and analysts aiming for informed decisions.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for analyzing portfolios related to Arcadia Biosciences, Inc. (RKDA).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Offer clients precise valuation insights for Arcadia Biosciences, Inc. (RKDA) stock.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotechnology firms like Arcadia Biosciences, Inc. (RKDA) are valued in the market.
What the Template Contains
- Historical Data: Includes Arcadia Biosciences, Inc.’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Arcadia Biosciences, Inc.’s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Arcadia Biosciences, Inc.’s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.